[Federal Register Volume 64, Number 88 (Friday, May 7, 1999)]
[Notices]
[Page 24712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-11504]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Research and Development Cooperative Studies Evaluation
Committee; Notice of Meeting
The Department of Veterans Affairs gives notice under Public Law
92-463 (Federal Advisory Committee Act) as amended, by section 5(c) of
Pub. L. 94-409, that a meeting of the Research and Development
Cooperative Studies Evaluation Committee will be held at the Marriott
Residence Inn, 500 Army Navy Drive, Arlington, VA 22202, May 11-13,
1999. The session on May 11 will begin at 7:30 a.m. until 5:45 p.m., on
May 12 from 7:30 a.m. until 5:00 p.m. and on May 13 from 7:30 a.m.
until 12:00 noon. The meeting will be for the purpose of reviewing the
following six new proposals: treatment of knee osteoarthritis, Type II
Diabetes, statins in reducing the risk of stroke, Pallidal procedure
for Parkinson's disease, homocysteinemia in kidney and end stage renal
disease, and genetic tissue banking in clinical research. The Committee
will also review the progress of four on going studies on
Antiarrhythmic Therapy, group treatment of PTSD, computer-assisted
neuropsychological screening battery and Naltrexone treatment of
alcoholism.
The Committee advises the Chief Research and Development Officer
through the Chief of the Cooperative Studies Program on the relevance
and feasibility of the studies, the adequacy of the protocols, and the
scientific validity and propriety of technical details, including
protection of human subjects.
The meeting will be open to the public from 7:30 a.m. to 8:00 a.m.
on all three days to discuss the general status of the program. Those
who plan to attend should contact Dr. Ping Huang, Coordinator, Research
and Development Cooperative Studies Evaluation Committee, Department of
Veterans Affairs, Washington, DC, (202-273-8295).
The meeting will be closed during the following portions: on May
11, from 8:15 a.m. until 5:45 p.m., on May 12, from 8:00 a.m. until
5:00 p.m. and on May 13 from 8:00 a.m. until 12:00 noon. These portions
of the meeting involve consideration of specific proposals in
accordance with provisions set forth in section 10(d) of Pub. L. 92-
463, as amended by Pub. L. 94-409, and 5 U.S.C. 552b(c)(6) and (9)(B).
During the closed sessions of the meeting, discussions and
recommendations will deal with qualifications of personnel conducting
the studies (the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy), as well as staff and
consultant critiques of research protocols, and similar documents, and
the medical records of patients who are study subjects (the premature
disclosure of which would significantly frustrate implementation of
proposed agency action regarding such research projects).
Dated: May 3, 1990.
By Direction of the Secretary.
Heyward Bannister,
Committee Management Officer.
[FR Doc. 99-11504 Filed 5-6-99; 8:45 am]
BILLING CODE 8320-01-M
